Fli-1, Friend Leukaemia Virus Integration 1 gene

Fli-1 protein is a member of the ETS family of DNA-binding transcription factors. Approximately 90% of Ewing's sarcoma/PNETs have a specific translocation, t(11;22)(q24;q12). This results in the fusion of EWS to Fli-1 and production of a fusion protein which is a more potent transcription factor than normal Fli-1. The EWS/Fli-1 fusion transcript is not specific to Ewing's sarcoma/PNET, having also been described in childhood soft tissue sarcomas with neural and myogenic differentiation3,4 and classic neuroblastoma5.

Both polyclonal (Fli-1p) and monoclonal (Fli-1m) antibodies are available.

Immunohistochemical expression

Immunoreactivity is nuclear.

Among small round cell tumours, it is specific to Ewing sarcoma/PNET and lymphoblastic lymphoma:

 

Ewing sarcoma/PNET

29/411

 

Rhabdomyosarcoma

0/321

Neuroblastoma

0/301

Poorly differentiated synovial sarcoma

0/81

Lymphoblastic lymphoma

7/81

Estheioneuroblastoma

0/81

Desmoplastic small round cell tumour

1/11

Mesenchymal chondrosarcoma

0/11

   
   
   

 

The sensitivity and specificity of polyclonal (Fli-1p) and monoclonal (Fli-1m) anti-Fli-1, CD99 and FISH with the EWSR1 (22q12) dual-colour break-apart probe have been compared6. In normal tissues, Fli-1p expression was restricted to haemopoietic and endothelial cells. However, Fli-1m was also expressed by the prostate, breast , colon and squamous epithelium.

 For each antibody, a threshold of 10% of tumour cells staining was set, cytoplasmic for CD99 and nuclear for Fli-1.

Ewing sarcoma/PNET

Controls

ROC-AUC

 

CD99

40/436

3/156

0.876

 

Fli-1m

42/436

6/156

0.796

 

Fli-1p

35/436

2/156

0.846

 

CD99+Fli-1m

40/436

3/156

0.886

 

CD99+Fli-1p

40/436

4/156

0.916

 

Fli-1m+Fli-1p

42/436

6/156

0.896

 

CD99+Fli-1m+Fli-1p

40/436

4/156

0.936

 

FISH

19/386

0/156

 

 
         

In conclusion, Fli-1m is sensitive but lacks specificity for EWS/PNET. The combination of CD99 and Fli-1p is optimal.

 

Angiosarcoma

20/222